Literature DB >> 28894919

'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.

Lorena Lorefice1, G Coghe2, G Fenu2, M Porta3, G Pilloni3, J Frau2, F Corona3, V Sechi4, M A Barracciu4, M G Marrosu2, M Pau3, E Cocco2.   

Abstract

Motor and cognitive disabilities are related to brain atrophy in multiple sclerosis (MS). 'Timed up and go' (TUG) has been recently tested in MS as functional mobility test, as it is able to evaluate ambulation/coordination-related tasks, as well as cognitive function related to mobility. The objective of this study is to evaluate the relationship between brain volumes and TUG performances. Inclusion criteria were a diagnosis of MS and the ability to walk at least 20 m. TUG was performed using a wearable inertial sensor. Times and velocities of TUG sub-phases were calculated by processing trunk acceleration data. Patients underwent to a brain MRI, and volumes of whole brain, white matter (WM), grey matter (GM), and cortical GM (C) were estimated with SIENAX. Sixty patients were enrolled. Mean age was 41.5 ± 11.6 years and mean EDSS 2.3 ± 1.2. Total TUG duration was correlated to lower WM (ρ = 0.358, p = 0.005) and GM (ρ = 0.309, p = 0.017) volumes. A stronger association with lower GM volume was observed for intermediate (ρ = 0.427, p = 0.001) and final turning (ρ = 0.390, p = 0.002). TUG is a useful tool in a clinical setting as it can not only evaluate patients' disability in terms of impaired functional mobility, but also estimate pathological features, such as grey atrophy.

Entities:  

Keywords:  Brain Atrophy; Mobility impairment; Multiple Sclerosis; Timed up and go

Mesh:

Year:  2017        PMID: 28894919     DOI: 10.1007/s00415-017-8612-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

Authors:  Arnaud Charil; Alain Dagher; Jason P Lerch; Alex P Zijdenbos; Keith J Worsley; Alan C Evans
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

2.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Correlation of clinical findings and brain volume data in multiple sclerosis.

Authors:  Yara Dadalti Fragoso; Paulo Roberto Wille; Marcelo Abreu; Joseph Bruno B Brooks; Ronaldo Maciel Dias; Juliana Avila Duarte; Luciano Farage; Alessandro Finkelsztejn; Alan Christmann Frohlich; Marcus Vinicius Magno Goncalves; Bruno V Sobreira Guedes; Leonardo Medeiros; Rodrigo Andre Oliveira; Flavio Diniz Ribas; Fernando Coronetti Gomes da Rocha; Gutemberg Augusto C Santos; Claudio Scorcine; Guilherme Lopes da Silveira; Carina Tellaroli Spedo; Carlos Bernardo Tauil; Juliana Santos Varela; Vera Lucia Ferreira Vieira
Journal:  J Clin Neurosci       Date:  2017-07-01       Impact factor: 1.961

4.  MRI as a marker for disease heterogeneity in multiple sclerosis.

Authors:  B Bielekova; N Kadom; E Fisher; N Jeffries; J Ohayon; N Richert; T Howard; C N Bash; J A Frank; L Stone; R Martin; G Cutter; H F McFarland
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

5.  Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis.

Authors:  G Allali; M Laidet; F Assal; O Beauchet; M Chofflon; S Armand; P H Lalive
Journal:  Eur Neurol       Date:  2012-01-10       Impact factor: 1.710

6.  Are static and functional balance abilities related in individuals with Multiple Sclerosis?

Authors:  Massimiliano Pau; Micaela Porta; Giancarlo Coghe; Federica Corona; Giuseppina Pilloni; Lorena Lorefice; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  Mult Scler Relat Disord       Date:  2017-04-11       Impact factor: 4.339

7.  The role of global and regional gray matter volume decrease in multiple sclerosis.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  J Neurol       Date:  2016-04-19       Impact factor: 4.849

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.

Authors:  Lukas Haider; Tobias Zrzavy; Simon Hametner; Romana Höftberger; Francesca Bagnato; Günther Grabner; Siegfried Trattnig; Sabine Pfeifenbring; Wolfgang Brück; Hans Lassmann
Journal:  Brain       Date:  2016-02-08       Impact factor: 13.501

10.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

View more
  1 in total

1.  Cognitive Function and Whole-Brain MRI Metrics Are Not Associated with Mobility in Older Adults with Multiple Sclerosis.

Authors:  Jessica F Baird; Robert W Motl
Journal:  Int J Environ Res Public Health       Date:  2021-04-16       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.